The Washington Post
Mar 27, 2024 - 19 min
All in 1 subscription.
Alzheimer's treatment has had a long and tumultuous history. However, that could be about to change. Laurie McGinley reports on the promising clinical trials of a new drug - Leqembi - that have ignited hope in the field. Read by Betsy Foldes Meiman.
If you want all the articles from The Washington Post click here to subscribe.